help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, P. M.
Right arrow Articles by Mason, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, P. M.
Right arrow Articles by Mason, J. I.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 1529-1532, Copyright © 1994 by Endocrine Society

ARTICLES

Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues

PM Stewart, BA Murry and JI Mason
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas.

11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) catalyzes the conversion of active cortisol to inactive cortisone, and regulates the access of cortisol to both the mineralocorticoid and glucocorticoid receptors. Two isoforms of 11 beta-HSD have been described, the cloned "type 1" NADP(H)-dependent dehydrogenase/oxo-reductase and a high affinity NAD-dependent dehydrogenase (type 2). In the fetus, 11 beta- HSD activity may serve to protect developing tissues from cortisol excess or may modulate the permissive actions of glucocorticoids. We have studied 11 beta-HSD activity and mRNA levels in human mid- gestational fetal tissues. Tissue homogenates were incubated with either 0.1 mumol/L cortisol and 400 mumol/L NAD, 2.5 mumol/L cortisol and 400 mumol/L NADP, or 0.1 mumol/L cortisone wither either 400 mumol/L NADPH or NADH. No activity (< 2.5% conversion) was observed in fetal tissues using either cortisone or 2.5 mumol/L cortisol as a substrate. 11-oxo-reductase activity was observed in maternally-derived decidua. In keeping with these activity studies, northern blot analysis of fetal tissue RNA and PCR-reverse transcriptase of type 1 11 beta-HSD mRNA indicated 11 beta-HSD mRNA in decidua, but failed to detect any type 1 11 beta-HSD mRNA transcripts in fetal tissues. In contrast when 0.1 mumol/L cortisol was used as a substrate in the presence of NAD, 11 beta-HSD activity was ubiquitous with highest levels seen in the kidney (131 +/- 16 (SE) pmoles cortisone formed/h/mg.protein) > lung > gonad > liver > colon. 11 beta-HSD activity in fetal tissues is mediated by the type 2, high affinity, isoform. The widespread distribution of this novel isoform suggests that it may play an important role in fetal development. Type 1 11 beta-HSD mRNA and activity are absent in mid- gestational fetal tissues, but present in maternally-derived decidua, suggesting that its ontogeny is a late-gestational of post-natal event.


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
A. E. Michael and A. T. Papageorghiou
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Hum. Reprod. Update, June 13, 2008; (2008) dmn021v1.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
H.-Y. Lee, T. J Acosta, M. Tanikawa, R. Sakumoto, J. Komiyama, Y. Tasaki, M. Piskula, D. J Skarzynski, M. Tetsuka, and K. Okuda
The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium
J. Endocrinol., April 1, 2007; 193(1): 127 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. R. SECKL and M. J. MEANEY
Glucocorticoid "Programming" and PTSD Risk
Ann. N.Y. Acad. Sci., July 1, 2006; 1071(1): 351 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. R. SECKL and M. J. MEANEY
Glucocorticoid Programming
Ann. N.Y. Acad. Sci., December 1, 2004; 1032(1): 63 - 84.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
P.M. Driver, S. Rauz, E.A. Walker, M. Hewison, M.D. Kilby, and P.M. Stewart
Characterization of human trophoblast as a mineralocorticoid target tissue
Mol. Hum. Reprod., December 1, 2003; 9(12): 793 - 798.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Quinkler and P. M. Stewart
Hypertension and the Cortisol-Cortisone Shuttle
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2384 - 2392.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Kajantie, L. Dunkel, U. Turpeinen, U.-H. Stenman, P. J. Wood, M. Nuutila, and S. Andersson
Placental 11{beta}-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 493 - 500.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. Nakamura, J. B. Stokes, and P. B. McCray Jr.
Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lung
Am J Physiol Cell Physiol, September 1, 2002; 283(3): C762 - C772.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. L. McTernan, N. Draper, H. Nicholson, S. M. Chalder, P. Driver, M. Hewison, M. D. Kilby, and P. M. Stewart
Reduced Placental 11{beta}-Hydroxysteroid Dehydrogenase Type 2 mRNA Levels in Human Pregnancies Complicated by Intrauterine Growth Restriction: An Analysis of Possible Mechanisms
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4979 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
P.M. Driver, M.D. Kilby, I. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart
Expression of 11{beta}-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies
Mol. Hum. Reprod., April 1, 2001; 7(4): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. C. McMillen, K. E. Warnes, M. B. Adams, J. S. Robinson, J. A. Owens, and C. L. Coulter
Impact of Restriction of Placental and Fetal Growth on Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 and Type 2 Messenger Ribonucleic Acid in the Liver, Kidney, and Adrenal of the Sheep Fetus
Endocrinology, February 1, 2000; 141(2): 539 - 543.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Morineau, J.-M. Marc, A. Boudi, H. Galons, M. Gourmelen, P. Corvol, L. Pascoe, and J. Fiet
Genetic, Biochemical, and Clinical Studies of Patients With A328V or R213C Mutations in 11{beta}HSD2 Causing Apparent Mineralocorticoid Excess
Hypertension, September 1, 1999; 34(3): 435 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P. J. Burton and B. J. Waddell
Dual Function of 11ß-Hydroxysteroid Dehydrogenase in Placenta: Modulating Placental Glucocorticoid Passage and Local Steroid Action
Biol Reprod, February 1, 1999; 60(2): 234 - 240.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Rogoff, Z. Smolenicka, I. Bergadá, G. Vallejo, M. Barontini, J. J. Heinrich, and P. Ferrari
The Codon 213 of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene Is a Hot Spot for Mutations in Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4391 - 4393.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Condon, C. Gosden, D. Gardener, P. Nickson, M. Hewison, A. J. Howie, and P. M. Stewart
Expression of Type 2 11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4490 - 4497.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Watanabe, K. Matsushita, J. B. Stokes, and P. B. McCray Jr.
Developmental regulation of epithelial sodium channel subunit mRNA expression in rat colon and lung
Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1227 - G1235.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Suzuki, H. Sasano, S. Suzuki, G. Hirasawa, J. Takeyama, Y. Muramatsu, F. Date, H. Nagura, and Z. S. Krozowski
11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Lung: Possible Regulator of Mineralocorticoid Action
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4022 - 4025.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
W. Song, J. Chen, W. L. Dean, R. N. Redinger, and R. A. Prough
Purification and Characterization of Hamster Liver Microsomal 7alpha -Hydroxycholesterol Dehydrogenase. SIMILARITY TO TYPE I 11beta -HYDROXYSTEROID DEHYDROGENASE
J. Biol. Chem., June 26, 1998; 273(26): 16223 - 16228.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. L. Ricketts, J. M. Verhaeg, I. Bujalska, A. J. Howie, W. E. Rainey, and P. M. Stewart
Immunohistochemical Localization of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Tissues
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1325 - 1335.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
R. Diaz, R. W. Brown, and J. R. Seckl
Distinct Ontogeny of Glucocorticoid and Mineralocorticoid Receptor and 11beta -Hydroxysteroid Dehydrogenase Types I and II mRNAs in the Fetal Rat Brain Suggest a Complex Control of Glucocorticoid Actions
J. Neurosci., April 1, 1998; 18(7): 2570 - 2580.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kitanaka, N. Katsumata, A. Tanae, I. Hibi, K.-I. Takeyama, H. Fuse, S. Kato, and T. Tanaka
A New Compound Heterozygous Mutation in the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene in a Case of Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4054 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. E. Smith, L. A. Salamonsen, P. A. Komesaroff, K. X. Z. Li, K. M. Myles, M. Lawrence, and Z. Krozowski
11{beta}-Hydroxysteroid Dehydrogenase Type II in the Human Endometrium: Localization and Activity during the Menstrual Cycle
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4252 - 4257.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
J. Bissonnette, S. Chambers, P. Collins, C. Lockwood, C. Mendelson, L. Myatt, M. L. Polan, W. H. Shen, and S. Szal
Strengthening Research in Departments of Obstetrics and Gynecology
Reproductive Sciences, May 1, 1997; 4(3): 124 - 129.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
P. C. White, T. Mune, and A. K. Agarwal
11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
Endocr. Rev., February 1, 1997; 18(1): 135 - 156.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
R. E. Smith, K. X. Z. Li, R. K. Andrews, and Z. Krozowski
Immunohistochemical and Molecular Characterization of the Rat 11{beta}-Hydroxysteroid Dehydrogenase Type II Enzyme
Endocrinology, February 1, 1997; 138(2): 540 - 547.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. C. White
Inherited Forms of Mineralocorticoid Hypertension
Hypertension, December 1, 1996; 28(6): 927 - 936.
[Abstract] [Full Text]

Home page
 HypertensionHome page
R. S. Lindsay, R. M. Lindsay, C. R.W. Edwards, and J. R. Seckl
Inhibition of 11ß-Hydroxysteroid Dehydrogenase in Pregnant Rats and the Programming of Blood Pressure in the Offspring
Hypertension, June 1, 1996; 27(6): 1200 - 1204.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society